结节病的正电子发射断层扫描成像
Positron emission tomography imaging in sarcoidosis.
作者信息
Vettiyil Beth, Gupta Nikitha, Kumar Rajesh
机构信息
Radiology Research Fellow, Diagnostic Radiology, Massachusetts General Hospital, Boston 02114, USA.
Department of Biology (Premed Student), New York University, New York 10012, USA.
出版信息
World J Nucl Med. 2013 Sep;12(3):82-6. doi: 10.4103/1450-1147.136731.
Abstract
Sarcoidosis is a chronic granulomatous disease of unknown origin. There are several modalities for diagnosis, staging and therapeutic management of patients with sarcoidosis. Among these, whole-body F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography is found to useful in patients with complex and multisystem forms of sarcoidosis. Other modalities include Gallium scanning, assesment of angiotensin converting enzyme levels in blood, chest radiography, mediastinoscopy etcetera.
摘要
结节病是一种病因不明的慢性肉芽肿性疾病。对于结节病患者，有多种诊断、分期及治疗管理方法。其中，全身F-18氟脱氧葡萄糖（FDG）正电子发射断层扫描/计算机断层扫描被发现对复杂的多系统结节病患者有用。其他方法包括镓扫描、血液中血管紧张素转换酶水平评估、胸部X线摄影、纵隔镜检查等。
相似文献
1
Positron emission tomography imaging in sarcoidosis.
World J Nucl Med. 2013 Sep;12(3):82-6. doi: 10.4103/1450-1147.136731.
2
The role of positron emission tomography-computed tomography/magnetic resonance imaging in the management of sarcoidosis patients.
Hell J Nucl Med. 2014 May-Aug;17(2):123-35.
3
F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis.
Am J Cardiol. 2015 Nov 15;116(10):1581-5. doi: 10.1016/j.amjcard.2015.08.025. Epub 2015 Sep 3.
4
FDG-PET Scan in Sarcoidosis: Clinical and Imaging Indications.
Curr Med Imaging Rev. 2019;15(1):4-9. doi: 10.2174/1573405614666180626120832.
5
Scar arcoidosis on F-FDG PET/CT.
Asia Ocean J Nucl Med Biol. 2019 Spring;7(2):185-187. doi: 10.22038/AOJNMB.2019.37888.1253.
6
Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis.
Chest. 2007 Dec;132(6):1949-53. doi: 10.1378/chest.07-1178. Epub 2007 Oct 9.
7
Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis.
Eur J Nucl Med Mol Imaging. 2008 May;35(5):933-41. doi: 10.1007/s00259-007-0650-8. Epub 2007 Dec 15.
8
The utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis.
J Nucl Med. 2012 Oct;53(10):1543-9. doi: 10.2967/jnumed.112.104380. Epub 2012 Aug 9.
9
F-fluorodeoxyglucose positron emission tomography is useful for the diagnosis of intraocular sarcoidosis in patients with a normal CT scan.
Br J Ophthalmol. 2019 Nov;103(11):1650-1655. doi: 10.1136/bjophthalmol-2018-313133. Epub 2019 Jan 18.
10
A case of sarcoidosis diagnosed by positron emission tomography/computed tomography.
Indian J Nucl Med. 2016 Jul-Sep;31(3):198-200. doi: 10.4103/0972-3919.183608.
引用本文的文献
1
Neurosarcoidosis, Coccidioidomycosis, or Both!
Int Med Case Rep J. 2023 Dec 28;16:887-895. doi: 10.2147/IMCRJ.S434632. eCollection 2023.
2
Macrovasculature and positron emission tomography (PET) standardized uptake value in patients with lung cancer.
Med Phys. 2021 Oct;48(10):6237-6246. doi: 10.1002/mp.15158. Epub 2021 Aug 25.
3
Atypical Optic Neuritis.
Curr Neurol Neurosci Rep. 2015 Dec;15(12):76. doi: 10.1007/s11910-015-0598-1.
本文引用的文献
1
Evaluating the Role of Fluorodeoxyglucose PET Imaging in the Management of Patients with Sarcoidosis.
PET Clin. 2006 Apr;1(2):141-52. doi: 10.1016/j.cpet.2006.01.002. Epub 2006 May 5.
2
F-18 FDG PET/CT as a valuable imaging tool for assessing treatment efficacy in inflammatory and infectious diseases.
Clin Nucl Med. 2010 Feb;35(2):86-90. doi: 10.1097/RLU.0b013e3181c7be8d.
3
F-18 fluorodeoxyglucose and F-18 fluorothymidine positron emission tomography/computed tomography imaging in a case of neurosarcoidosis.
Clin Nucl Med. 2010 Feb;35(2):67-70. doi: 10.1097/RLU.0b013e3181c7c149.
4
Early documentation of therapeutic response at 6 weeks following corticosteroid therapy in extensive sarcoidosis: promise of FDG-PET.
Clin Nucl Med. 2009 Oct;34(10):689-90. doi: 10.1097/RLU.0b013e3181b53155.
5
18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis.
Eur J Nucl Med Mol Imaging. 2009 Jul;36(7):1131-7. doi: 10.1007/s00259-009-1097-x. Epub 2009 Mar 4.
6
Functional imaging of inflammatory diseases using nuclear medicine techniques.
Semin Nucl Med. 2009 Mar;39(2):124-45. doi: 10.1053/j.semnuclmed.2008.10.006.
7
FDG-PET and MIBI-Tc SPECT as follow-up tools in a patient with cardiac sarcoidosis requiring a pacemaker.
Cardiovasc J Afr. 2008 Nov-Dec;19(6):309-10.
8
Laryngeal sarcoidosis detected by FDG positron emission tomography.
Clin Nucl Med. 2008 Dec;33(12):878-9. doi: 10.1097/RLU.0b013e31818bf2f5.
9
Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis.
Eur J Nucl Med Mol Imaging. 2008 May;35(5):933-41. doi: 10.1007/s00259-007-0650-8. Epub 2007 Dec 15.
10
Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis.
Chest. 2007 Dec;132(6):1949-53. doi: 10.1378/chest.07-1178. Epub 2007 Oct 9.
Zotero 插件